Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Trimetazidine

A metabolic anti-anginal medicine developed in France in the 1970s: it protects heart cells when they receive little oxygen and is used in angina pectoris, added to other medicines. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It nudges the heart to burn more glucose and fewer fatty acids: glucose delivers the same energy while using less oxygen, a valuable advantage when blood flow is poor.

TrimetazidineGo to the active ingredient →
TrimetazidineActive ingredientTrimetazidineCat. No. P-T214-001CAS 5011-34-7
TroxipideImpurityTroxipideCat. No. P-T214-041CAS 30751-05-4

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.